Target-specific immunoPET Imaging of Digestive System Carcinoma
This study tests a new type of imaging scan called PET/CT that uses special markers to find cancer in the digestive system (stomach, colon, pancreas, etc.). Researchers want to understand how well this imaging method works and how it shows both normal and cancerous areas in the body.
Key Objective:This trial is testing whether a new targeted imaging method can more accurately detect and identify digestive system cancers.
Who to Consider:People diagnosed with or suspected to have cancer of the digestive system may want to consider enrolling to receive this advanced diagnostic imaging.
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18-75 years old and of either sex； 2. Histologically confirmed diagnosis of digestive system carcinoma or suspected digestive system carcinoma by diagnostic imaging; 3. Capable of giving signed informed consent, including compliance with the requirements and restrictions listed in the informed consent form (ICF) and this protocol. Exclusion Criteria: 1. Pregnancy； 2. Severe hepatic and renal insufficiency; 3. History of serious surgery in the last month; 4. Allergic to antibody or single-domain antibody radiopharmaceuticals.